Takeda Pharmaceutical Co Ltd - ADR operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Co Ltd - ADR with three other
pharmaceutical manufacturers in North America:
sales of $2.08 billion
of which 44%
was Drug Delivery Solutions),
Dr.Reddy's Laboratories Ltd
of which 82%
was Global Generics), and
Eisai Company Limited
of which 54%
was Pharmaceutical Business -Japan).
Takeda Pharmaceutical Co Ltd - ADR reported sales of $16.02 billion
March of 2017.
increase of 6.4%
versus 2016, when the company's sales were $15.06 billion.
Despite this increase, sales are still
below the level achieved in 2015, when Takeda Pharmaceutical Co Ltd - ADR
reported sales of $16.12 billion.
Sales of Healthcare saw an increase
that was more than double the company's growth rate: sales were up
14.5% in 2017, from
$667.18 million to $763.79 million.
Takeda Pharmaceutical Co Ltd - ADR also saw significant increases in sales in
Other (up 13.9% to $745.61 million)